Orum Therapeutics Inc
KOSDAQ:475830
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
O
|
Orum Therapeutics Inc
KOSDAQ:475830
|
KR |
|
Recharge Metals Ltd
ASX:REC
|
AU |
|
Pininfarina SpA
MIL:PINF
|
IT |
|
Blue Water Global Group Inc
OTC:BLUU
|
US |
|
Mathew Easow Research Securities Ltd
BSE:511688
|
IN |
|
Guotai Junan International Holdings Ltd
F:GUE
|
HK |
|
B
|
Brazil Potash Corp
AMEX:GRO
|
CA |
|
Meta Platforms Inc
NASDAQ:META
|
US |
|
U
|
Universal Corp
F:UVV
|
US |
|
T
|
Thaitheparos PCL
SET:SAUCE
|
TH |
|
Sumitomo Forestry Co Ltd
TSE:1911
|
JP |
|
O
|
Osaka Gas Co Ltd
F:OSA
|
JP |
|
G
|
Gagan Gases Ltd
BSE:524624
|
IN |
|
S
|
Sinar Terang Mandiri PT Tbk
IDX:MINE
|
ID |
|
R
|
Radian Group Inc
SWB:RAG
|
US |
|
Greiffenberger AG
F:GRF
|
DE |
|
Electro Optic Systems Holdings Ltd
ASX:EOS
|
AU |
Bankruptcy Probability
Orum Therapeutics Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Orum Therapeutics Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| KR |
O
|
Orum Therapeutics Inc
KOSDAQ:475830
|
1.1T KRW |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
AbbVie Inc
NYSE:ABBV
|
454.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
204.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences, Inc
NASDAQ:GILD
|
178.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
130.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
80.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
54.3B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Moderna Inc
NASDAQ:MRNA
|
57.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
82.2B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Natera Inc
NASDAQ:NTRA
|
47.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Revolution Medicines Inc
NASDAQ:RVMD
|
43.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Orum Therapeutics Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Orum Therapeutics Inc has total debt of 23.7B KRW. This includes both short-term (0 KRW) and long-term (23.7B KRW) debt.
You can find a full breakdown on its Balance Sheet.